Target intelligence / Profile preview

Testis anion transporter 1 (SLC26A8)

Target
SLC26A8
Molecular classification
Transporter, Solute carrier family, Anion exchanger, Membrane protein
01

Overview

Testis anion transporter 1 (SLC26A8) is a transmembrane protein encoded by the SLC26A8 gene, highly and specifically expressed in male germ cells—especially spermatocytes[1][3][5]. It is a member of the solute carrier (SLC) 26 family of anion transporters and mediates the exchange of multiple anions, most notably chloride, sulfate, bicarbonate, and oxalate across the plasma membrane[1][5]. SLC26A8 is localized primarily to the sperm flagellum and is critical for normal sperm motility, capacitation, and structural integrity of the sperm tail and annulus[1][2][5]. The protein physically and functionally interacts with the cystic fibrosis transmembrane conductance regulator (CFTR), a relationship essential for activating CFTR-dependent Cl^- and HCO₃⁻ fluxes required for the PKA-dependent phosphorylation cascades that underlie sperm motility and capacitation[1][2][4][7]. Mutations in SLC26A8, particularly compound heterozygous variants, have been related to male infertility characterized by asthenozoospermia (reduced sperm motility) and structural sperm abnormalities; however, not all variants are pathogenic, and a clear genotype-phenotype link can be complex[5]. SLC26A8 does not currently have known therapeutic drugs or interventions targeting it directly. Its clinical significance is primarily as a mechanism for idiopathic male infertility and a potential biomarker for certain infertility phenotypes[5].

Other names
SLC26A8TAT1Anion exchange transporterSolute carrier family 26 member 8Testis anion transporter 1AZONSPGF3Anion transporter/exchanger-8Solute carrier family 26 (anion exchanger), member 8
02

Mechanism of action

Not applicable (no drugs identified targeting SLC26A8)

03

Biological functions

Transmembrane anion exchange (Cl^-, SO₄²⁻, HCO₃⁻, oxalate)Regulation of sperm motilitySperm capacitationSperm tail differentiationProtein-protein interaction with CFTRRegulation of ion fluxes in sperm
04

Disease associations

Male infertility (particularly asthenozoospermia)Sperm structural defectsPotential indirect relevance to cystic fibrosis pathophysiology via CFTR interactionOther (complex mechanisms in infertility)
05

Safety considerations

No notable safety issues or therapeutic challenges documented; research applications focus primarily on fertility
06

Biomarkers

Mutations/variants in SLC26A8 may be biomarkers for forms of male infertility (e.g., severe asthenozoospermia)

Beyond the preview

Go deeper on Testis anion transporter 1 (SLC26A8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testis anion transporter 1 (SLC26A8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call